PRESS RELEASE published on 12/01/2023 at 13:00, 2 years 5 months ago HanchorBio to Present at the ESMO Immuno-Oncology 2023 Annual Congress HanchorBio Inc. announces poster presentation at ESMO-IO 2023 Annual Congress, featuring innovative immuno-biomedicines targeting solid tumors and hematological malignancies HanchorBio Inc. ESMO-IO 2023 Immuno-biomedicines Solid Tumors Hematological Malignancies
PRESS RELEASE published on 10/03/2023 at 13:30, 2 years 7 months ago HanchorBio Announces First Patient Dosed in the Phase 1 Multi-Regional Clinical Trial of HCB101
PRESS RELEASE published on 08/28/2023 at 13:30, 2 years 8 months ago HanchorBio and Henlius Announce Strategic Collaboration to Develop Innovative Immunotherapies
PRESS RELEASE published on 07/24/2023 at 13:30, 2 years 9 months ago HanchorBio Announces Taiwan FDA IND Approval for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
PRESS RELEASE published on 04/17/2023 at 13:30, 3 years ago HanchorBio Announces US IND Clearance for the Multi-Regional Clinical Trial of HCB101 to Treat Solid and Hematological Malignancies
Published on 05/14/2026 at 03:15, 35 minutes ago Jaguar Delivers Strong Adjusted Earnings and Strategic Production Restart of MTL (Turmalina Mine) in Q1 2026
Published on 05/13/2026 at 23:30, 4 hours 20 minutes ago CCL Industries Announces Results for 2026 First Quarter
Published on 05/13/2026 at 23:15, 4 hours 35 minutes ago Avino Delivers Record Q1 2026 Financial Results
Published on 05/14/2026 at 03:20, 30 minutes ago TCL Electronics (01070.HK) Maintains Strong Growth in Q1 2026
Published on 05/14/2026 at 01:05, 2 hours 45 minutes ago THE ROYAL MINT SHINES A LIGHT ON PINK FLOYD WITH FIRST EVER UK COMMEMORATIVE COIN
Published on 05/13/2026 at 22:20, 5 hours 29 minutes ago Rumble Announces Initial Results of Exchange Offer for Northern Data
Published on 05/13/2026 at 20:18, 7 hours 32 minutes ago EQS-Adhoc: Northern Data Group Q1 2026 – Above the Preliminary Ranges Communicated on 8 April 2026
Published on 05/13/2026 at 17:45, 10 hours 5 minutes ago Infotel confirms its return to growth in Q1 2026 with revenue up 8.6%. Proposed dividend of €2 per share for 2025.
Published on 05/13/2026 at 17:45, 10 hours 5 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of April 30, 2026
Published on 05/13/2026 at 17:40, 10 hours 10 minutes ago Report on share repurchases from 6 to 12 May 2026
Published on 05/13/2026 at 16:00, 11 hours 50 minutes ago MONTHLY INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES
